9 research outputs found
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ ΠΈ ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΠΎΠΌ Ρ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ Π½Π° ΠΊΠΎΠ½Π΅ΡΠ½ΡΡ ΡΡΠ°Π΄ΠΈΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ
The blood levels of pro-inflammatory cytokines associated with the development of cardiac pathology, markers of endothelial dysfunction, as well as indicators of the inflammatory response in alcohol-dependent individuals with chronic heart failure (CHF) of NYHA functional classes III and IV, as well as in patients with CHF, not complicated by alcoholism, and in alcohol-dependent individuals with no signs of heart failure. A significant increase in the plasma content of IL-6, IL-8, TNFa, VEGF-A, Endothelin 1-21, s-VCAM-1 and s-ICAM-1 in patients with CHF, regardless of alcohol abuse, with a pronounced tendency to higher concentrations in the final stage of heart failure by NYHA. In alcohol-dependent patients with no signs of CHF, the plasma levels of pro-inflammatory cytokines and endothelial dysfunction markers increased to a lesser extent than in the presence of CHF. The peculiarity of CHF in patients with alcoholism in comparison with CHF not burdened by alcohol abuse is the excessive secretion of TNFa, which is an important activator of inflammation, cell death and inhibition of contractile function of the myocardium.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π² ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ², ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠ΅ΡΠ΄ΡΠ°, ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΈΠ½Π΄ΠΈΠΊΠ°ΡΠΎΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ Ρ Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΎΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ Π»ΠΈΡ, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ (Π₯Π‘Π) ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΊΠ»Π°ΡΡΠΎΠ² III ΠΈ IV ΠΏΠΎ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ NYHA, Π° ΡΠ°ΠΊΠΆΠ΅ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π₯Π‘Π, Π½Π΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΠΎΠΉ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΠΎΠΌ, ΠΈ Ρ Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΎΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ Π»ΠΈΡ Π±Π΅Π· ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡΠΎΠ²ΠΈ IL-6, IL-8, TNFa, VEGF-A, ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ½Π°-1, s-VCAM-1 ΠΈ s-ICAM-1 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π₯Π‘Π, Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ, Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠΉ ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΠ΅ΠΉ ΠΊ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠΌ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΠΌ ΠΏΡΠΈ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΉ ΡΡΠ°Π΄ΠΈΠΈ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ ΠΏΠΎ NYHA. Π£ Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΎΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±Π΅Π· ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² Π₯Π‘Π ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π»ΠΎ Π² ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ, ΡΠ΅ΠΌ ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠΈ Π₯Π‘Π. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡ Π₯Π‘Π Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΠΎΠΌ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π₯Π‘Π, Π½Π΅ ΠΎΡΡΠ³ΠΎΡΠ΅Π½Π½ΠΎΠΉ Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΠ΅ΠΌ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ, ΡΠΎΡΡΠΎΠΈΡ Π² ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΠΊΡΠ΅ΡΠΈΠΈ TNFa, ΡΠ²Π»ΡΡΡΠ΅Π³ΠΎΡΡ Π²Π°ΠΆΠ½ΡΠΌ Π°ΠΊΡΠΈΠ²Π°ΡΠΎΡΠΎΠΌ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ, Π³ΠΈΠ±Π΅Π»ΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈ ΡΠ³Π½Π΅ΡΠ΅Π½ΠΈΡ ΡΠΎΠΊΡΠ°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π°
Characteristics of immune blood cells in patients with dilated cardiomyopathy: Genesis alcohol and non-alcoholic cardiomyopathy, ischemic type. The comparative role of inflammation TX1 should be -, TX2 - and D classes
The article shows the role of alcohol-induced dilated cardiomyopathy chronic inflammatory process Th-type, and in the pathogenesis of ischemic dilated cardiomyopathy Genesis of the inflammation TX1 should be - and TX2 types. A marked increase in the activity of serum arginase patients, which confirms the opinions expressed in the literature proposals for the use of tests arginase as highly sensitive marker of violations of coronary functions already in the early stages. However, revealed a negative correlation between the activity of arginase and reduced ejection fraction of the left ventricle and atrial fibrillation in patients ICMP show more about the protective role of this enzyme, and do not prove the feasibility of inhibition arginase as a therapeutic target for dilated cardiomyopathy, alcoholic Genesis
Characteristics of immune blood cells in patients with dilated cardiomyopathy: Genesis alcohol and non-alcoholic cardiomyopathy, ischemic type. The comparative role of inflammation TX1 should be -, TX2 - and D classes
The article shows the role of alcohol-induced dilated cardiomyopathy chronic inflammatory process Th-type, and in the pathogenesis of ischemic dilated cardiomyopathy Genesis of the inflammation TX1 should be - and TX2 types. A marked increase in the activity of serum arginase patients, which confirms the opinions expressed in the literature proposals for the use of tests arginase as highly sensitive marker of violations of coronary functions already in the early stages. However, revealed a negative correlation between the activity of arginase and reduced ejection fraction of the left ventricle and atrial fibrillation in patients ICMP show more about the protective role of this enzyme, and do not prove the feasibility of inhibition arginase as a therapeutic target for dilated cardiomyopathy, alcoholic Genesis
ΠΠ·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΡ Π»ΠΎΠΊΡΡΠΎΠ² Π³Π΅Π½ΠΎΠ² IL-6 (RS1800795)ΠΈ IL-8 (RS4073)Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠΈΡ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΈ ΠΎΡΡΡΠΎΠΌ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡ
The article presents the peculiarities of the influence of polymorphic loci of the promoter regions of cytokine genes on the level of cytokines involved in the development of acute alcoholic hepatitis (AAH). Material and methods. 51 patients abusing alcohol were included in the study (mean age 50.1Β±9.1 years, 38 (78%) men). Two groups were formed: the comparison group (n=24) included patients, who were abusing alcohol, without somatic pathology, and the observation group AAH (n=27). In 44 patients (CG-24, AAH-20), concentrations of IL-6, IL-8 and allelic variants of polymorphic loci of the IL-6 interleukin genes (rs1800795), IL-8 (rs4073) were determined. Results. The levels of IL-6, IL-8 were significantly increased in patients with AAH compared with the patients from the comparison group. IL-6 correlates with ESR, IL-8 correlates with C-reactive protein. In patients with AAH, an association of the C allele, the CC and CG genotypes of the rs1800795 locus with an increased level of IL-6 was detected, with no differences in frequency between the groups. An association of the rs4073 T allele with the risk of developing the disease and a high level of IL-8 was detected. Conclusion. An acute inflammatory process in the liver is accompanied by an increase in interleukins, which correlate with the general indicators of inflammation. Carriage of the rs4073 T allele is associated with the risk of AAH and high IL-8 levels in these patients. Carrier rs1800795 locus C allele is associated with high levels of IL-6 in AAH.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ Π²Π»ΠΈΡΠ½ΠΈΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΡ
Π»ΠΎΠΊΡΡΠΎΠ² ΠΏΡΠΎΠΌΠΎΡΠΎΡΠ½ΡΡ
ΠΎΠ±Π»Π°ΡΡΠ΅ΠΉ Π³Π΅Π½ΠΎΠ² ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² Π½Π° ΡΡΠΎΠ²Π΅Π½Ρ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ², ΡΡΠ°ΡΡΠ²ΡΡΡΠΈΡ
Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΎΡΡΡΠΎΠ³ΠΎ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° (ΠΠΠ). ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΊΠ»ΡΡΠ΅Π½ 51 ΠΏΠ°ΡΠΈΠ΅Π½Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 50,1Β±9,1 Π»Π΅Ρ, 38 (78%) ΠΌΡΠΆΡΠΈΠ½), Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ. ΠΡΠ»ΠΈ ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Ρ 2 Π³ΡΡΠΏΠΏΡ: Π³ΡΡΠΏΠΏΠ° ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ (n=24) - Π»ΠΈΡΠ°, Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΠ΅ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ, Π±Π΅Π· ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ Π³ΡΡΠΏΠΏΠ° Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ - ΠΠΠ (n=27). Π£ 44 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (ΠΠ‘-24, ΠΠΠ-20) ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ IL-6, IL-8 ΠΈ Π°Π»Π»Π΅Π»ΡΠ½ΡΠ΅ Π²Π°ΡΠΈΠ°Π½ΡΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΡ
Π»ΠΎΠΊΡΡΠΎΠ² Π³Π΅Π½ΠΎΠ² ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½ΠΎΠ² IL-6 (rs1800795), IL-8 (rs4073). Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ΡΠΎΠ²Π½ΠΈ IL-6, IL-8 Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΠΏΠΎΠ²ΡΡΠ°Π»ΠΈΡΡ ΠΏΡΠΈ ΠΠΠ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π³ΡΡΠΏΠΏΠΎΠΉ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ. IL-6 ΠΊΠΎΡΡΠ΅Π»ΠΈΡΡΠ΅Ρ Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ Π‘ΠΠ, IL-8 ΠΊΠΎΡΡΠ΅Π»ΠΈΡΡΠ΅Ρ Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ Π‘-ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ°. Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΠΠ Π²ΡΡΠ²Π»Π΅Π½Π° ΡΠ²ΡΠ·Ρ Π°Π»Π»Π΅Π»Ρ Π‘, Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Π‘Π‘ ΠΈ CG Π»ΠΎΠΊΡΡΠ° rs1800795 Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΌ ΡΡΠΎΠ²Π½Π΅ΠΌ IL-6, Π±Π΅Π· ΡΠ°Π·Π»ΠΈΡΠΈΠΉ ΠΏΠΎ ΡΠ°ΡΡΠΎΡΠ΅ ΠΌΠ΅ΠΆΠ΄Ρ Π³ΡΡΠΏΠΏΠ°ΠΌΠΈ. ΠΡΡΠ²Π»Π΅Π½Π° Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΡ Π°Π»Π»Π΅Π»Ρ Π’ Π»ΠΎΠΊΡΡΠ° rs4073 Ρ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ Π²ΡΡΠΎΠΊΠΈΠΌ ΡΡΠΎΠ²Π½Π΅ΠΌ IL-8. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΡΡΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΏΡΠΎΡΠ΅ΡΡ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½ΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΊΠΎΡΡΠ΅Π»ΠΈΡΡΡΡ Ρ ΠΎΠ±ΡΠΈΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ. ΠΠΎΡΠΈΡΠ΅Π»ΡΡΡΠ²ΠΎ Π°Π»Π»Π΅Π»Ρ Π’ Π»ΠΎΠΊΡΡΠ° rs4073 ΡΠ²ΡΠ·Π°Π½ΠΎ Ρ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠΠ ΠΈ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΡΠΎΠ²Π½Ρ IL-8 Ρ Π΄Π°Π½Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠΎΡΠΈΡΠ΅Π»ΡΡΡΠ²ΠΎ Π°Π»Π»Π΅Π»Ρ Π‘ Π»ΠΎΠΊΡΡΠ° rs1800795 ΡΠ²ΡΠ·Π°Π½ΠΎ Ρ Π²ΡΡΠΎΠΊΠΈΠΌΠΈ ΡΡΠΎΠ²Π½ΡΠΌΠΈ IL-6 ΠΏΡΠΈ ΠΠΠ
ΠΠ½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΈΠΌΠΌΡΠ½ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΈ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ
E role of immune-inflammatory and genet- ic factors in the development of liver fibrosis in patients with alcohol liver disease (ALD).Material and methods. Forty-six patients with ALD (35 males, mean age 50.2Β±11.5 years) were enrolled in our study and were distributed into two groups depending on the stage of liver fibrosis, that was determined by transient elastometry (F0+1, n=10; F3+4, n=36). We measured serum interleukin(IL)-6, IL-8, tumor necrosis factor (TNF)-Ξ±, VEGF-A, sICAM-1,ET-1 levels and gene polymorphism of TNF-Ξ± (rs1800629), IL-6 (rs1800795), VEGF-A (rs699947), ICAM1 (rs281437), ET-1 (rs1800541), IL-8 (rs4073).Results. Serum IL-6, IL-8, TNF-Ξ±, VEGF-A, sICAM-1 levelsin patients with ALD were higher than the reference values. Serum IL-6, IL-8, sICAM-1 and ET-1 levels depended on the degree of alcoholic liver fibrosis. Degree of liver fibrosis sig- nificantly correlated with IL-6 (r = 0.60), IL-8 (r = 0.77), sICAM-1 (r = 0.58) and ET-1 (r = 0.56). There were no signifi-cant differences in the TNF-Ξ± and VEGF-A levels between thetwo groups. Different alleles and genotypes of the studied genes occurred with similar frequency in the two groups. In both groups, VEGF-A level in patients with genotypes CA of the rs699947 C2578A gene was higher than in patients with genotype AA (p = 0.04 and p = 0.01). In advanced fibrosis, genotype TT of the rs281437 -451CT gene was associated with a higher sICAM-1 compared with genotype CC (p=0.05)Conclusion. Patients with ALD presented with increased levels of pro-inflammatory cytokines (IL-6, IL-8) and molecules of endothelial dysfunction (EΠ’1, sICAM-1). Genotype CA ofΠ¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΈ Π³Π΅Π½Π΅-ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΡ, ΡΡΠ°ΡΡΠ²ΡΡΡΠΈΠ΅ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡ-ΡΠΈΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΈΠ²ΠΊΠ»ΡΡΠ΅Π½Ρ 46 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ50,2Β±11,5 Π»Π΅Ρ, 35 ΠΌΡΠΆΡΠΈΠ½) Ρ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠΉΠ±ΠΎΠ»Π΅Π·Π½ΡΡ ΠΏΠ΅ΡΠ΅Π½ΠΈ (ΠΠΠ), ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΡΡ
Π½Π°Π³ΡΡΠΏΠΏΡ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΡΠΈΠ±ΡΠΎΠ·Π°ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΠΊΠΎΡΠΎΡΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π½Π΅ΠΏΡΡ-ΠΌΠΎΠΉ ΡΠ»Π°ΡΡΠΎΠΌΠ΅ΡΡΠΈΠΈ: 1-Ρ - F0+1 (n=20), 2-Ρ - F3+4 (n=36). Π£ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΠ·ΠΌΠ΅ΡΡΠ»ΠΈ ΠΊΠΎΠ½-ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π° (ΠΠ)-6, ΠΠ-8, ΡΠ°ΠΊΡΠΎΡΠ°Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ (Π€ΠΠ)-Ξ±, VEGF-A, sICAM-1,ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ½Π° (ΠΠ’)-1 ΠΈ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌ Π³Π΅Π½ΠΎΠ²Π€ΠΠ-Ξ± (rs1800629), ΠΠ-6 (rs1800795),VEGF-A (rs699947), ICAM-1 (rs281437),ΠΠ’-1 (rs1800541), ΠΠ-8 (rs4073).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΠΠ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°-ΡΠΈΠΈ ΠΠ-6, ΠΠ-8, Π€ΠΠ-Ξ±, VEGF-A, sICAM-1Π±ΡΠ»ΠΈ Π²ΡΡΠ΅ ΡΠ΅ΡΠ΅ΡΠ΅Π½ΡΠ½ΡΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ. Π£ΡΠΎΠ²Π½ΠΈΠΠ-6, ΠΠ-8, sICAM-1 ΠΈ ΠΠ’-1 Π·Π°Π²ΠΈΡΠ΅Π»ΠΈ ΠΎΡ ΡΡΠ΅ΠΏΠ΅-Π½ΠΈ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ Π²ΠΎ 2-ΠΉ Π³ΡΡΠΏ-ΠΏΠ΅ Π±ΡΠ»ΠΈ Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² 1-ΠΉ (p0,05). Π ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏ-ΠΏΠ°Ρ
Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠΌ Π‘Π rs699947C2578A ΡΡΠΎΠ²Π΅Π½Ρ VEGF-A Π±ΡΠ» Π²ΡΡΠ΅, ΡΠ΅ΠΌ ΡΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠΌ ΠΠ (Ρ=0,04 ΠΈ Ρ=0,01,ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² 2-ΠΉ Π³ΡΡΠΏΠΏΡ Π³Π΅Π½ΠΎ-ΡΠΈΠΏ Π’Π’ rs281437 -451C>T Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π»ΡΡ ΡΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠΌ ΡΡΠΎΠ²Π½Π΅ΠΌ sICAM-1 ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡΡ ΡΠ°ΠΊΠΎΠ²ΡΠΌ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠΌ Π‘Π‘ (Ρ=0,05).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΠ±ΡΠΎΠ·Π°ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉ-ΠΊΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ ΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉΠ΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΡΡΠΌΠΎ ΡΠ²ΡΠ·Π°Π½Ρ Ρ ΠΏΠ»ΠΎΡ-Π½ΠΎΡΡΡΡ ΠΏΠ΅ΡΠ΅Π½ΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ ΠΈ ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΠΎΠΌ Ρ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ Π½Π° ΠΊΠΎΠ½Π΅ΡΠ½ΡΡ ΡΡΠ°Π΄ΠΈΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ
The blood levels of pro-inflammatory cytokines associated with the development of cardiac pathology, markers of endothelial dysfunction, as well as indicators of the inflammatory response in alcohol-dependent individuals with chronic heart failure (CHF) of NYHA functional classes III and IV, as well as in patients with CHF, not complicated by alcoholism, and in alcohol-dependent individuals with no signs of heart failure. A significant increase in the plasma content of IL-6, IL-8, TNFa, VEGF-A, Endothelin 1-21, s-VCAM-1 and s-ICAM-1 in patients with CHF, regardless of alcohol abuse, with a pronounced tendency to higher concentrations in the final stage of heart failure by NYHA. In alcohol-dependent patients with no signs of CHF, the plasma levels of pro-inflammatory cytokines and endothelial dysfunction markers increased to a lesser extent than in the presence of CHF. The peculiarity of CHF in patients with alcoholism in comparison with CHF not burdened by alcohol abuse is the excessive secretion of TNFa, which is an important activator of inflammation, cell death and inhibition of contractile function of the myocardium.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π² ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ², ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠ΅ΡΠ΄ΡΠ°, ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΈΠ½Π΄ΠΈΠΊΠ°ΡΠΎΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ Ρ Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΎΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ Π»ΠΈΡ, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ (Π₯Π‘Π) ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΊΠ»Π°ΡΡΠΎΠ² III ΠΈ IV ΠΏΠΎ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ NYHA, Π° ΡΠ°ΠΊΠΆΠ΅ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π₯Π‘Π, Π½Π΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΠΎΠΉ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΠΎΠΌ, ΠΈ Ρ Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΎΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ Π»ΠΈΡ Π±Π΅Π· ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡΠΎΠ²ΠΈ IL-6, IL-8, TNFa, VEGF-A, ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ½Π°-1, s-VCAM-1 ΠΈ s-ICAM-1 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π₯Π‘Π, Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ, Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠΉ ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΠ΅ΠΉ ΠΊ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠΌ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΠΌ ΠΏΡΠΈ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΉ ΡΡΠ°Π΄ΠΈΠΈ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ ΠΏΠΎ NYHA. Π£ Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΎΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±Π΅Π· ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² Π₯Π‘Π ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π»ΠΎ Π² ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ, ΡΠ΅ΠΌ ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠΈ Π₯Π‘Π. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡ Π₯Π‘Π Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΠΎΠΌ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π₯Π‘Π, Π½Π΅ ΠΎΡΡΠ³ΠΎΡΠ΅Π½Π½ΠΎΠΉ Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΠ΅ΠΌ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ, ΡΠΎΡΡΠΎΠΈΡ Π² ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΠΊΡΠ΅ΡΠΈΠΈ TNFa, ΡΠ²Π»ΡΡΡΠ΅Π³ΠΎΡΡ Π²Π°ΠΆΠ½ΡΠΌ Π°ΠΊΡΠΈΠ²Π°ΡΠΎΡΠΎΠΌ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ, Π³ΠΈΠ±Π΅Π»ΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈ ΡΠ³Π½Π΅ΡΠ΅Π½ΠΈΡ ΡΠΎΠΊΡΠ°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π°
Serum level of ILβ8 and polymorphic locus rs4073 β352 a / t of the ILβ8 gene with alcoholic hepatitis
To study the serum level of interleukin-8 (IL-8) and the polymorphic locus rs4073 -352 A/T of the IL-8 gene (IL-8) in patients with alcoholic hepatitis (AH), depending on the severity of the disease
Association of SNPs in the Promoter Regions of VEGF (rs699947 ΠΈ rs2010963), ICAM1 (rs281437) and ET-1 (rs1800541) with Serum Levels of Related Proteins and Alcoholic Liver Cirrhosis Risk [ΠΠ·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΡ Π»ΠΎΠΊΡΡΠΎΠ², ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΡΡ Π² ΠΏΡΠΎΠΌΠΎΡΠΎΡΠ½ΡΡ ΠΎΠ±Π»Π°ΡΡΡΡ Π³Π΅Π½ΠΎΠ² VEGF (rs699947 ΠΈ rs2010963), ICAM1 (rs281437) ΠΈ ET-1 (rs1800541), Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ²ΡΡ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΈ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ]
BACKGROUND: Uncontrolled use of alcohol can lead to the development of cirrhosis of the liver, which is manifested by fibrosis with the formation of regenerative nodes, an increase in pressure in the portal vein system and impaired liver function. Hepatic endothelium dysfunction during the formation of portal hypertension is accompanied by an increase in the level of protein molecules involved in the functioning of the endothelium: vascular endothelial growth factor A (VEGF-A), a soluble form of the intercellular adhesion molecule (s-ICAM-1) and endothelin-1 (ET -one). It is assumed that elevated levels of VEGF-A, s-ICAM-1 and ET-1 in alcoholic liver cirrhosis (AHC) may be interconnected with the structure of polymorphic loci, the promoter regions of the respective genes, which in turn may be a genetic risk factor for developing cirrhosis. AIMS: Investigate the relationship of carriage of variant forms of polymorphic loci located in the promoter regions of VEGF-A, ICAM-1 and ET-1 with the level of the corresponding proteins in the blood serum and the risk of AHC. MATERIALS AND METHODS: The main group consisted of patients with pathological dependence on alcohol, aggravated by cirrhosis of the liver (AHC, n=60). The control group consisted of persons suffering from alcohol abuse, without liver pathology (AA, n=24). The observation period was the period of hospitalization. The serum levels of VEGF-A, s-ICAM-1 and ET-1 were evaluated by enzyme immunoassay. The distribution of variant forms of polymorphic loci located in the promoter regions of the VEGF-A genes (rs699947 and rs2010963), ICAM1 (rs281437) and ET-1 (rs1800541) in the studied sample was performed by real-time PCR. RESULTS: The development of alcoholic cirrhosis was accompanied by a significant increase in the concentration of VEGF-A, s-ICAM-1 and ET-1 in serum. At the same time, direct correlations between the concentrations of VEGF-A, s-ICAM-1 and ET-1 in serum and the diameter of the portal vein in persons with liver cirrhosis were revealed. Patients with AHC are often carriers of the G allele of rs1800541 locus, located in the promoter of the ET-1 gene, compared with individuals suffering from control without liver pathology, which is associated with an increased risk of developing cirrhosis in alcohol dependence. The carriage of the C allele rs699947, as well as the C allele rs2010963 located in the promoter of the VEGF gene was associated with an increased level of VEGF-A in the AHC compared to carriers of this allele in the AA group. In addition, in the group of patients with AHC, carriers of allele C, homozygous CC genotype and heterozygous GC genotype of rs2010963 locus compared with carriers of G allele or homozygous GG genotype, respectively, were characterized by elevated serum VEGF-A levels. CONCLUSION: Carrier allele G of the rs1800541 locus (ET-1) is a risk factor for liver cirrhosis with alcohol abuse. The carriage of the C allele rs699947, as well as the C allele rs2010963 located in the promoter of the VEGF gene, can determine the elevated serum VEGF-A level in the AHC. Β© 2018 Izdatel'stvo Meditsina. All rights reserved
ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ, ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΡΡΠ°ΡΡΡΠ°, Π³Π΅Π½Π° ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π° COL1A1_1 Π½Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ
Liver fibrosis and its final stage - cirrhosis is one of the causes of deaths in chronic liver diseases. Alcohol and its metabolites mediate the accumulation of extracellular collagen, leading to fibrosis mediated by cytokine imbalances, processes of fibrogenesis and fibrolysis. The purpose. To investigate the immune-inflammatory factors and association between the COL1 A1_1 C/A (rs1107946) polymorphism and liver fibrosis in patients abusing alcohol. Πethods. 46 patients were genotyped (the period of alcohol consumption was 15.6Β±9.5 years) with liver fibrosis, alcohol abusers. They were divided into 2 groups depending on the stage of liver fibrosis: 1- F0+1, n=10; 2- F3+4, n=36. Exclusion criteria were chronic non-alcoholic liver disease, acute alcoholic hepatitis, general inflammatory and autoimmune diseases. We analyzed serum concentrations of interleukin (IL)-6, IL-8, TNF-Ξ±, VEGF-A, s-ICAM-1, ET-1 and polymorphism of the COL1A1_1 gene was determined using the Real-Time PCR analysis. The stage of liver fibrosis was identified with the elastography method (FibroScan, Echosens, France). Results. The levels of IL-6, IL-8, s-ICAM-1, ET-1 depended on the degree of alcoholic liver fibrosis. The liver fibrosis was significantly correlated with the level of IL-6 (r = 0.6), IL-8 (r = 0.77), s-ICAM-1 (r = 0.58), ET- 1 (r = 0.56) (p 0.05). It was found that the frequency of allele A among patients was 38.3% which is significantly higher than in the control group (12.5%; Ρ=0.005768). The frequency of heterozygotes CA was not significantly different between the group of patients and the control group (38% and 25% respectively, p = 0.4425). Homozygous AA genotypes were revealed only in patients with liver fibrosis, the frequency was 19.1%. Conclusion. A positive correlation between the level of cytokines (IL-8, IL-6), endothelial dysfunction molecules (ET1, sICAM-1) and the level of liver fibrosis was revealed. The presence of allele A of the COL1A1_1 gene may be one of the genetic factors involved in the development of liver fibrosis in patients abusing alcohol.Π€ΠΈΠ±ΡΠΎΠ· ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ Π΅Π³ΠΎ ΠΊΠΎΠ½Π΅ΡΠ½Π°Ρ ΡΡΠ°Π΄ΠΈΡ - ΡΠΈΡΡΠΎΠ· ΡΠ²Π»ΡΡΡΡΡ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· ΠΏΡΠΈΡΠΈΠ½ Π»Π΅ΡΠ°Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² ΠΏΡΠΈ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΡ
ΠΏΠ΅ΡΠ΅Π½ΠΈ. ΠΠ»ΠΊΠΎΠ³ΠΎΠ»Ρ ΠΈ Π΅Π³ΠΎ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΡ Π²ΡΠ·ΡΠ²Π°ΡΡ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π°, ΠΏΡΠΈΠ²ΠΎΠ΄ΡΡΠ΅Π³ΠΎ ΠΊ ΡΠΈΠ±ΡΠΎΠ·Ρ, Π²ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ Π΄ΠΈΡΠ±Π°Π»Π°Π½ΡΠ°, ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΡΠΈΠ±ΡΠΎΠ³Π΅Π½Π΅Π·Π° ΠΈ ΡΠΈΠ±ΡΠΎΠ»ΠΈΠ·Π°. Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ°ΠΊΡΠΎΡΡ, Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° Π³Π΅Π½Π° ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π° I ΡΠΈΠΏΠ° COL1A1_1 C/A (rs1107946) Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ. ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ°. ΠΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΎ 46 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠΈΠ±ΡΠΎΠ·ΠΎΠΌ ΠΏΠ΅ΡΠ΅Π½ΠΈ, Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ (ΡΡΠΎΠΊ ΡΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Ρ 15,6Β±9,5 Π»Π΅Ρ). ΠΡΡΠΏΠΏΡ ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Ρ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΠ°Π΄ΠΈΠΈ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π½Π΅ΠΏΡΡΠΌΠΎΠΉ ΡΠ»Π°ΡΡΠΎΠΌΠ΅ΡΡΠΈΠΈ: 1-Ρ - F0+1 (n=20), 2-Ρ - F3+4 (n=36). ΠΡΠΈΡΠ΅ΡΠΈΠΈ ΠΈΡΠΊΠ»ΡΡΠ΅Π½ΠΈΡ: ΠΎΡΡΡΡΠΉ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΡΠΉ Π³Π΅ΠΏΠ°ΡΠΈΡ, Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π½Π΅Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½Π΅Π·Π°, ΠΎΠ±ΡΠΈΠ΅ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΈ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΡΠ΅ ΠΏΡΠΎΡΠ΅ΡΡΡ. Π£ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π° (ΠΠ)-6, ΠΠ-8, Π€ΠΠ-Π°Π»ΡΡΠ°, VEGF-A, s-ICAM-1, ΠΠ’-1. ΠΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌ Π³Π΅Π½Π° COL1A1_1 ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Real-Time PCR. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° Π³Π΅Π½Π° ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π° Π±ΡΠ»ΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 30 Π·Π΄ΠΎΡΠΎΠ²ΡΡ
ΠΌΡΠΆΡΠΈΠ½ ΠΈ ΠΆΠ΅Π½ΡΠΈΠ½. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ΡΠΎΠ²Π½ΠΈ ΠΠ-6, ΠΠ-8, s-ICAM-1, ET-1 Π·Π°Π²ΠΈΡΠΈΠ»ΠΈ ΠΎΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ: Π²ΠΎ 2-ΠΉ Π³ΡΡΠΏΠΏΠ΅ ΠΎΠ½ΠΈ Π±ΡΠ»ΠΈ Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² 1-ΠΉ (p0,05). Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΡΠΈΠ±ΡΠΎΠ·ΠΎΠΌ ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΡΡ, ΡΠ°ΡΡΠΎΡΠ° Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π°Π»Π»Π΅Π»Ρ Π ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ (38,3% ΠΏΡΠΎΡΠΈΠ² 12,5%, Ο2 = 7,6212; Ρ=0,005768). Π§Π°ΡΡΠΎΡΠ° Π³Π΅ΡΠ΅ΡΠΎΠ·ΠΈΠ³ΠΎΡ Π‘Π ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π½Π΅ ΠΎΡΠ»ΠΈΡΠ°Π΅ΡΡΡ Π² Π³ΡΡΠΏΠΏΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ (38% ΠΈ 25% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, Ρ=0,4425). ΠΠΎΠΌΠΎΠ·ΠΈΠ³ΠΎΡΡ ΠΠ Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ ΡΠΎΠ»ΡΠΊΠΎ Π² Π³ΡΡΠΏΠΏΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΡΠΈΠ±ΡΠΎΠ·ΠΎΠΌ ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΡΠ°ΡΡΠΎΡΠ° Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 19,1%. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΠ²Π»Π΅Π½Π° ΠΏΡΡΠΌΠ°Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½Π°Ρ ΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² (IL-8, IL-6), ΠΌΠΎΠ»Π΅ΠΊΡΠ» ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ (EΠ’1, sICAM-1) Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ. ΠΠ°Π»ΠΈΡΠΈΠ΅ Π°Π»Π»Π΅Π»Ρ Π Π³Π΅Π½Π° COL1A1_1 ΠΌΠΎΠΆΠ΅Ρ ΡΠ²Π»ΡΡΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
, Π·Π»ΠΎΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΡ
Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ